Inventor
Pierre Corvol
Inventor
Paris, FR
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms19%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
A61KPreparations for medical, dental or toiletry purposes11%
C07HSugars11%
C07KPeptides11%
Y10TTechnical subjects covered by former us classification11%
C12NMicroorganisms or enzymes8%
C07CAcyclic or carbocyclic compounds5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
PatentTitleYear
7,582,797'Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same'20097,235,687'Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same'20076,482,797'N-terminal site selective inhibitors of human angiotensin conversion enzyme (ACE)'20026,340,708'Pharmaceutical composition comprising at least one aminopeptidase A inhibitor'20026,165,727'Method to determine predisposition to hypertension'20005,998,145'Method to determine predisposition to hypertension'19995,763,168'Method to determine predisposition to hypertension'19985,736,323'Agents and procedures for the study of the genetic polymorphism of the angiotensin I converting enzyme'19985,589,584'Angiotensinogen gene variants and predisposition to hypertension'19965,480,793'Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension'19965,359,045'Nucleic acid coding for the human angiotensin converting enzyme (ACE), and its uses, especially for the in vitro diagnosis of arterial hypertension'19944,481,192'Acid-protease inhibiting peptide derivatives'19844,185,096'Novel derivatives of pepstatin, their preparation and compositions containing them'1980Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1980Patents assigned to ANVAR (1)· patent assignee history
1980–2009Based in Paris, FR· patent location history
1984–2009Patents assigned to INST NAT SANTE RECH MED (11)· patent assignee history
1996–2000Patents assigned to UNIV UTAH RES FOUND (3)· patent assignee history
2002Patents assigned to CENTRE NAT RECH SCIENT (1)· patent assignee history
2002Patents assigned to COMMISSARIAT ENERGIE ATOMIQUE (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INST NAT SANTE RECH MED | 11 | 1984–2009 |
| UNIV UTAH RES FOUND | 3 | 1996–2000 |
| ANVAR | 1 | 1980 |
| CENTRE NAT RECH SCIENT | 1 | 2002 |
| COMMISSARIAT ENERGIE ATOMIQUE | 1 | 2002 |
Locations
| Location | Patents | Span |
|---|---|---|
| Paris, FR | 13 | 1980–2009 |